The Australians' Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the ex
The Ecstasy and Related Drug Reporting System (EDRS) is a national drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets.
Tapentadol is a centrally-acting opioid analgesic registered for use in Australia to treat moderate to severe pain.
Nitrous oxide, a colourless gas used for the purpose of sedation and pain relief, is also a food additive when used as a propellant for whipped cream.
This bulletin series reports on trends in the availability and type of substances sold on the internet via cryptomarkets over the last 12 months (new bulletin released every four months). The current bulletin focuses on analysis of listings from 1st January 2019 to 31st January 2020.
Opioid overdose is a major public health issue associated with substantial morbidity and mortality in Australia.
This bulletin describes trends in methamphetamine use over 20 years among two sentinel samples in Darwin, the Northern Territory.
This bulletin synthesises data from multiple sources to provide an up-to-date insight into methamphetamine use in Tasmania.
Latest release date
March 2020
Research suggests that substance use is associated with high levels of unsafe and risky sexual health behaviours, which may place people at risk of sexually transmitted diseases.
The Illicit Drug Reporting System (IDRS) is a national drug monitoring system intended to identify emerging t
